RUNSTACK Unveils Hypergraph Long-Term Memory for Agentic Systems
NORTH YORK, Ontario, Nov. 10, 2025 (GLOBE NEWSWIRE) -- RUNSTACK Inc., a…
ProFrac Holding Corp. Reports Third Quarter 2025 Results
WILLOW PARK, Texas--(BUSINESS WIRE)--ProFrac Holding Corp. (NASDAQ: ACDC) (“ProFrac”, or the “Company”)…
Palabra AI Acquires Talo and Launches Suite of Real-Time Multilingual Communication Products
LONDON--(BUSINESS WIRE)--Palabra AI, the company behind sub-second speech-to-speech translation, today announced the…
GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF
EVerZom’s investigational drug candidate EViv, developed to treat ACLF, using its proprietary…
GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting 2025
Preclinical studies demonstrated significant efficacy on systemic inflammation and organ function in…
Jinhong Gas Expands Global Presence with New Project in Spain
SUZHOU, China, Nov. 9, 2025 /PRNewswire/ -- Jinhong Gas Co., Ltd. has…
Kia and Motability Operations Strengthen Collaboration to Deliver Inclusive Electric Mobility
Motability Operations and Kia sign MOU to enhance accessible mobility and advance…
In Response to a Broader FDA Investigation, ByHeart Initiates a Voluntary Recall of Two Batches of Infant Formula
NEW YORK--(BUSINESS WIRE)--ByHeart, a next-generation baby nutrition company, announced today that, out…
Cango Inc. Announces October 2025 Bitcoin Production and Mining Operations Update
HONG KONG, Nov. 3, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango"…
Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
November 08, 2025 17:13 ET | Source: Intellia Therapeutics, Inc. Deep, stable…